Journals / Sakarya Tıp Dergisi / 2016 / Cilt: 6 - Sayı: 4

Intravenous Ascorbic Acid and Oral Methylene Blue Treatment in Prilocaine-induced Methemoglobinemia: A Case Report

İntravenöz Askorbik Asid İle Birlikte Oral Metilen Mavisi Kullanılan, Prilokaine Bağlı Methemoglobinemi: Vaka Takdimi

Pages
245–248
Publication Date
2016-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In methemoglobinemia cases, treatment options might include oral methylene blue combined with intravenous ascorbic acid. ( Sakarya Med J 2016, 6(4):245-248 ).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Methemoglobinemia is a disorder characterized by the presence of a higher than normal level of methemoglobin (is a form of hemoglobin that contains ferric [Fe3+] rather than ferrous [Fe2+] iron) in the blood.
📊
Key Findings & Data:Blood methemoglobin level was found as 31.5% and was diagnosed with methemoglobinemia.
💡
Conclusion & Impact:In methemoglobinemia cases, treatment options might include oral methylene blue combined with intravenous ascorbic acid. ( Sakarya Med J 2016, 6(4):245-248 ).
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Askorbik asid · methemoglobinemi · metilen mavisi

Abstract

Methemoglobinemia is a disorder characterized by the presence of a higher than normal level of methemoglobin (is a form of hemoglobin that contains ferric [Fe3+] rather than ferrous [Fe2+] iron) in the blood. Methemoglobinemia can develop due to acquired and congenital / genetic causes. Congenital methemoglobinemia develops due to structural deficiencies in hemoglobin and methemoglobin reduction enzyme disorders. Acquired methemoglobinemia develops due to the exposure drugs, chemicals and foods having oxidant property as well as some disorders observed during infancy. Three and half month-old boy was admitted with respiratory distress and cyanosis after circumcision due to a a local anesthetic drug, prilocaine. Blood methemoglobin level was found as 31.5% and was diagnosed with methemoglobinemia. Three hours after intravenous ascorbic acid and oral methylene blue were administered, clinical symptoms were improved and methemoglobin level was found to be normal at 12th hours. In methemoglobinemia cases, treatment options might include oral methylene blue combined with intravenous ascorbic acid. ( Sakarya Med J 2016, 6(4):245-248 ).

Özet

Methemoglobinemi; kanda methemoglobin (iki değerli ferröz hemoglobin yerine üç değerli ferrik demir içeren türü) düzeyinin normalden daha yüksek olmasına bağlı gelişen klinik tablodur. Methemoglobinemi konjenital/genetik ve edinsel nedenlere bağlı gelişebilir. Konjenital methemoglobinemiler, yapısal hemoglobin bozuklukları ve methemoglobin redüksiyon enzimlerindeki eksikliklere bağlı olarak gelişir. Edinsel methemoglobinemiler ise oksidan özelliğe sahip ilaç, kimyasal madde ve gıdalara maruziyet yanında süt çocukluğu döneminde görülen bazı hastalıklara bağlı gelişebilir. Prilokain içeren lokal anestezik kullanılarak sünnet yapıldıktan sonra solunum sıkıntısı ve siyanozu başlayan 3.5 aylık erkek bebek hastanemize yatırıldı. Kan methemoglobin düzeyi %31.5 bulundu ve methemoglobinemi tanısı konuldu. İntravenöz askorbik asid ile birlikte oral metilen mavisi uygulanan hastanın 3. saatinde klinik bulgularında düzelme izlendi ve 12. saatinde methemoglobin düzeyi normal olarak bulundu. Methemoglobinemi vakalarında intravenöz askorbik asid ile birlikte oral metilen mavisi de tedavi seçenekleri arasında değerlendirilebilir. ( Sakarya Tıp Dergisi 2016, 6(4):245-248 )

🔖

Cite This Article

Elmas, B., Koçer, G. B., Özdemir, Ö. (2016). Intravenous Ascorbic Acid and Oral Methylene Blue Treatment in Prilocaine-induced Methemoglobinemia: A Case Report. Sakarya Tıp Dergisi, Cilt: 6 - Sayı: 4, 245–248. https://ajindex.com/articles/261460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Referans1. Caner İ, Ziraatçi Ö Taştekin A. Methemoglobinemia due to prilocaine which treated with oral methylene blue. Çocuk Hast Derg 2011;5:172-176. Referans2. Shamriz O, Cohen-Glickman I, Reif S, Shteyer E. Methemoglobinemia induced by lidocaine-prilocaine cream. Isr Med Assoc J 2014;16:250-4. Referans3. Coleman MD, Coleman NA. Drug Induced Methemoglobinemia. Drug Safety 1996;14:394-405. Referans4. Benini D, Vivo L, Fanos V. Acquired methemoglobinemia: a case report. Pediatr Med Chir. 1998;20:411-3. Referans5. Bozaykut A, Güven G, Erkum T, Pulat Seren L, Yıldırım E, Ünver A. Topikal anestezik krem uygulamasına sekonder methemoglobinemi: Olgu sunumu. Türk Pediatri Arşivi 2004;39:88- 90.